English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
Sep 19, 2023 21:00 HKT
CGFNS Appoints New Chief Technology Officer to Lead its Digital Transformation
Sep 15, 2023 09:00 HKT
Vegan Cats Challenge Carnivorous Expectations
Sep 15, 2023 08:00 HKT
专注于中国双抗的开发 武汉友芝友生物宣布于港交所主板上市计划
Sep 13, 2023 11:32 HKT
專注於中國雙抗的開發 武漢友芝友生物宣佈於港交所主板上市計劃
Sep 13, 2023 11:31 HKT
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK
Sep 13, 2023 11:30 HKT
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot
Sep 12, 2023 20:00 HKT
中国抗体SM17新药研究申请再获国家药监局批准
Sep 12, 2023 09:50 HKT
中國抗體SM17新藥研究申請再獲國家藥監局批准
Sep 12, 2023 09:49 HKT
SinoMab's IND Application of SM17 has once again Received Approval from NAMP
Sep 12, 2023 09:48 HKT
Q&M Dental Group Sets the Gold Standard for Best Investor Relations at Singapore Corporate Awards
Sep 11, 2023 10:00 HKT
透云生物率先实现工业化量产莱茵衣藻
Sep 07, 2023 13:18 HKT
透雲生物率先實現工業化量產萊茵衣藻
Sep 07, 2023 13:17 HKT
UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer
Sep 06, 2023 21:00 HKT
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals
Aug 29, 2023 13:00 HKT
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
Aug 28, 2023 20:23 HKT
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
Aug 28, 2023 19:30 HKT
中国生物制药(1177.HK)公布2023中期业绩
Aug 25, 2023 19:14 HKT
中國生物製藥(1177.HK)公佈2023中期業績
Aug 25, 2023 19:13 HKT
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
Aug 25, 2023 19:12 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: